Chinook Therapeutics, Inc.

EVENTIDE ASSET MANAGEMENT, LLC

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/15/2023

Shares

1,927,000

Value ($000)

74,035

Weight

1.3%

2022 Q4 - 2023 Q2 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/15/2023	74,035	1.3%	1,927,000	6/30/2023
2023 Q1	5/15/2023	33,326	0.6%	1,439,564	3/31/2023
2022 Q4	2/13/2023	9,663	0.2%	368,811	12/31/2022